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Abstract Estradiol administration induces peroxisome prolif-
eration and the production of 3-hydroxy fatty acid pheromones in
the uropygial glands of the duck, but not in the goose gland,
which does not produce such pheromones. We isolated a
peroxisome proliferator-activated receptor (PPAR)Q1 cDNA
from a duck uropygial gland cDNA library. Northern blots
revealed two transcripts, PPARQ1 and Q2, and showed that
PPARQ was expressed at higher levels than PPARK in the
uropygial gland of the duck. Although PPARQ2 was expressed in
both duck and goose uropygial gland, PPARQ1 was expressed
only in the duck gland, which responds to estrogen by peroxisome
proliferation. In NIH 3T3 transfected cells, PPARQ1 was
activated by peroxisome proliferators such as Wy-14 643,
clofibric acid and Ly-171 883 causing induction of the target
marker gene. By cotransfection with a plasmid containing K-cis-
retinoic acid receptor RXRK, the induction increased up to
9-fold. These results suggest that PPARQ1 may be involved in
peroxisome proliferation while PPARQ2 may be involved in lipid
metabolism.
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1. Introduction
In rodents peroxisome proliferation is induced by a group
of structurally diverse chemicals called peroxisome prolifera-
tors [1]. Peroxisomes produce reactive oxygen and hydrogen
peroxide that can cause oxidative damage to DNA that may
lead to carcinogenesis [2]. A group of nuclear hormone recep-
tors called peroxisome proliferator-activated receptors medi-
ate the transcriptional activation of the genes that encode
enzymes involved in peroxisomal fatty acid L-oxidation. To
date at least three isoforms of PPAR, K, L and Q, have been
found in amphibians, rodents and humans [3^11]. Targeted
disruption of the gene that encodes the K form in mice elim-
inated the pleiotropic e¡ects of peroxisome proliferators [12].
Recently PPARQ has received more attention since PPARQ is
highly expressed in adipose tissues and is uniquely involved in
the conversion of ¢broblasts into cells of the adipose lineage
[13^16]. Recently it has been shown to be involved in the
regulation of in£ammatory responses [17,18] and in the for-
mation of foam cells from macrophages in the presence of
oxidized low-density lipoprotein (oxLDL) [19^21]. Thus
PPARs can play central and diverse roles in lipid metabolism.
Alternative splicing of one gene product yields two transcripts
of PPARQ, Q1 and Q2 [7,22], and the ratio of the two isoforms
varies with both species and tissues [23^27]. In rodents PPARQ2
is the major form synthesized in adipose tissues, suggesting
that this form may be involved in adipocyte di¡erentiation [6],
and PPARQ1 has been found only as a minor component in
both adipose and non-adipose tissues [23,24]. In cattle PPARQ1
was expressed at higher levels than Q2 in spleen, lung, and
ovary [25]. In human, while only PPARQ1 was expressed in
muscle [26], the ratio of PPARQ2/Q1 in adipose tissues was
found to be correlated with the extent of human obesity
[27], consistent with the observation that PPARQ2 was respon-
sible for adipocyte di¡erentiation. However, the function of
PPARQ1 remains unknown.
A new role for peroxisomes was discovered when it was
found that during the mating season the uropygial glands of
female mallards, which normally produce wax esters, prolifer-
ate peroxisomes to produce sex pheromones, 3-hydroxy fatty
acid diesters [28]. That this seasonal switch in lipid synthesis is
mediated by estrogens was shown by the observation that
peroxisome proliferation and diester production could be in-
duced in the uropygial gland with no detectable changes in the
liver by intramuscular administration of estradiol [29]. The
high degree of correlation of hepatic peroxisome proliferation
with liver cancer observed in rodents [2] raises the possibility
that estrogen-induced peroxisome proliferation in the estrogen
target tissues could play a similar role in carcinogenesis in
such tissues. To date nothing is known about the molecular
basis of estrogen-induced peroxisome proliferation and
PPARs have not been cloned from any avian tissues.
In this paper, we report the cloning of PPARQ1 cDNA from
mallard duck uropygial gland. We show that the Q1 and Q2
isoforms of PPAR are produced at similar levels in the duck
uropygial gland, whereas only the Q2 form is expressed in the
goose uropygial gland, which does not produce peroxisomes
in response to estradiol treatment. The unique occurrence of
PPARQ1 as a major form of this receptor in the duck gland
implicates it in estradiol-induced peroxisome proliferation. We
also show here that in transient transfection the duck PPARQ1
can be activated by peroxisome proliferators such as Wy-
14,643, and more potently by prostaglandin J2 series.
2. Materials and methods
2.1. Chemicals
Wy-14 643 ([4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid)
was purchased from Chemsyn Science Laboratories (Lenexa, KS,
USA). Ly-171 883 and 9-cis-retinoic acid were purchased from Biomol
Research Laboratories (Plymouth Meeting, PA, USA). The prosta-
glandins were obtained from either Biomol Research Laboratories or
from Cayman Chemical Company (Ann Arbor, MI, USA). Clo¢bric
acid and other chemicals were obtained from Sigma. The chemicals
used in transient transfection were dissolved in ethanol or DMSO as
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stock solution and applied to the medium at ¢nal concentrations in
the range of 0.1^0.2%.
2.2. Animals
1^2 year old mallard ducks (Anas platyrhynchos) were purchased
from Whistling Wings (Hanover, IL, USA) and maintained in out-
door cages. They were injected daily intramuscularly into the £ight
muscles with 0.1 ml of either 17L-estradiol benzoate (1 mg dissolved in
0.1 ml of 2.5% ethanol in olive oil) for the experimental group or the
ethanol/olive mixture for the control group [29].
2.3. Isolation of duck PPARQ cDNA
Poly(A) mRNA was isolated from the mallard duck uropygial
glands with the Fastrack kit, following the instruction of the manu-
facturer (Invitrogen), using 100 mg tissue per ml of the denaturing
bu¡er. Then 2 Wg of mRNA was heated at 70‡C for 5 min in the
presence of NotI primer adapter, and incubated with 5U reverse tran-
scription bu¡er, RNasin ribonuclease inhibitor, 4.0 mM sodium py-
rophosphate, and AMV reverse transcriptase in a volume of 25 Wl at
42‡C for 2 h (Promega). The second strand synthesis reaction was
performed by adding 23 units of E. coli DNA polymerase I and 0.8
units of E. coli RNase H. The double stranded cDNA was cloned into
the EcoRI-digested Vgt11 vector (Stratagene). Recombinant plaques
(0.5 million) of this library were screened with a 180-bp DNA frag-
ment from the DNA binding region of PPAR. This probe was ob-
tained by PCR using the double stranded cDNA of duck uropygial
gland as the template, and with two degenerate primers that corre-
spond to the amino acid sequences from the DNA binding region of
PPAR. The sequences of the primers were as follows: 5P-GGG GAT
CCT (A/C/G/T)TG (C/T)GG (A/C/G/T)GA (C/T)AA (G/A)GC and
5P-GGG AAT TCC (G/T)(A/G)C A(A/C/G/T)T (A/G)(C/T)T G(A/
G)C A. Four clones were puri¢ed after three sequential rounds of
plating and hybridization. Bacteriophage DNA from the selected pos-
itive plaques was prepared according to standard methods [30]. cDNA
insert fragments were eletroeluted from 1% agarose gel and subcloned
into the EcoRI site of vector pGEM7Z (Promega) and sequenced with
speci¢c primers.
2.4. Isolation of duck PPARK cDNA fragment
About 0.3^1 Wg of mRNA from untreated duck tissues was used.
The reverse transcription reaction was performed at 42‡C for 1 h with
superscript II reverse transcriptase. The template RNA was removed
by incubation with RNase H at 55‡C for 20 min and the resultant
DNA was used as template for PCR reactions. Two oligonucleotides
for PCR were designed based on the cDNA sequence which is specif-
ically conserved among all of the known PPARKs from human, ro-
dents and Xenopus laevis : primer ap5, 5P-AAG AAC TTC AAC ATG
AAC; and primer ap6, 5P-CGA TCT CCA CAG CAA AT. The
following degenerate oligonucleotide primer speci¢c for PPARK iso-
form was designed for priming the reverse transcription reaction of
the ¢rst strand of cDNA from mRNA: primer ap4, 5P-G(G/C)A C(G/
A)T G(T/C/G)A C(A/G)AT (A/C/G)C(C/T) CTC. For the PCR re-
actions 40 cycles were performed, with 1 min at 94‡C for denaturing,
1 min at 48‡C for annealing and 2 min at 72‡C for extension in each
cycle. The PCR product was subcloned and at least three clones from
each reaction were sequenced to assure that point mutations did not
arise during PCR.
2.5. Northern blot analysis
Poly(A) mRNA was prepared from estrogen-treated or untreated
mallard duck tissues with the Fastrack kit. Each RNA sample (2 Wg)
was denatured in formamide and formaldehyde at 65‡C for 15 min,
and resolved on a 1% agarose gel containing 0.66 M formaldehyde.
The RNA was transferred to Duralon-UV membrane (Stratagene)
with Turboblotter rapid downward transfer system and baked for
2 h at 80‡C. The 2.4-kb duck PPARQ1 EcoRI fragment and the
519-bp PCR product of duck PPARK cDNA were labeled with [K-
32P]dCTP using Rediprime DNA labeling system (Amersham). The
membranes were prehybridized at 42‡C for 2 h in a solution contain-
ing 6U SSPE, 5U Denhard’s reagent, 50% formamide, 0.1% SDS and
100 Wg of denatured salmon sperm DNA, then hybridized with the
labeled DNA probes at 42‡C overnight. The membranes were washed
in 2U SSPE and 0.1% SDS at room temperature for 10 min twice and
in 0.1U SSPE and 0.1% SDS at 65‡C for 15 and 25 min. Following
washing the membranes were exposed to X-ray ¢lm.
2.6. Primer extension analysis
A synthetic 30-mer oligonucleotide complementary to the duck
PPARQ1 mRNA close to the 5P end (primer EXT1, GAT CCA
CTG GGC TAA TTC CAA AAT TAA TGG) was labeled with
[Q-32P]ATP and T4 polynucleotide kinase. The products were precipi-
tated with 2 M sodium acetate and ethanol and resuspended in water.
Either 10^20 Wg of mRNA or 60^100 Wg of total RNA, which was
prepared with RNeasy total RNA kit (Qiagen) was incubated in a
total volume of 16 Wl with labeled primers in 5U reverse transcriptase
bu¡er containing 250 mM Tris-HCl, 375 mM KCl and 15 mM
MgCl2. The annealing was done by heating at 85‡C for 15 min and
cooling on ice. Then DTT, dNTP and BRL Superscript II RNase H3
reverse transcriptase (200 U) were added and the synthesis of the ¢rst
strand of cDNA was performed at 50‡C for 1 h. The reaction was
stopped by heating at 70‡C for 15 min and RNase A was used to
degrade the template RNA. After extraction with phenol/chloroform,
synthesized DNA was precipitated by sodium acetate and ethanol in
the presence of 25 Wg of yeast tRNA. The ¢nal product was dissolved
in 10 Wl of sequencing stop bu¡er and analyzed on a 6% polyacrymide
sequencing gel.
2.7. Plasmids and transient transfection assay
The EcoRI fragment of duck PPARQ1 cDNA was subcloned into
the EcoRI site of mammalian expression vector pcDNA3 (Invitrogen).
Two complementary 39-mer oligonucleotides were synthesized based
on the peroxisome proliferator response element, PPRE, from rat
fatty acyl-CoA oxidase promoter with BglII site overhangs: 5P-gat
ct G ACT CCC GAA CGT GAC CTT TGT CCT GGT CCC CTa
and 5P-gat ctA GGG GAC CAG GAC AAA GGT CAC GTT CGG
GAG TCa. They were phosphorylated with T4 polynucleotide kinase
and extracted with phenol/chloroform. The products were annealed to
double strand by boiling followed by cooling to room temperature,
and subcloned into the BglII site of pGL2-promoter vector which
contains the SV40 promoter upstream of the luciferase gene (Prom-
ega). The positive clones identi¢ed from colony hybridization were
further analyzed by sequencing and the clone with three consecutive
copies of PPRE was used in the transfection experiments as the
PPRE-containing reporter vector. The mouse K-cis-retinoic acid re-
ceptor (RXRK) plasmid was kindly provided by Dr. Ronald M. Evans
(Salk Institute).
NIH 3T3 cells were maintained in DMEM high glucose with 10%
calf serum. Transient transfection was performed using the Lipofect-
AMINE reagent (BRL) by following the standard protocol. Brie£y,
the cells were split and switched to DMEM without phenol red and
with calf serum which had been treated with 2% dextran-coated char-
coal. On the next day the cells, which were 60^80% con£uent in
35-mm plates, were transfected with 200 ng of duck PPARQ1, 200 ng
of PPRE-containing luciferase reporter, and 1 Wg of L-galactosidase
expression vector or with 200 ng of mRXRK as speci¢ed. pBluescript
plasmid was used to make up the total amount of DNA to 2 Wg per
sample and each assay was done in triplicate. After 5 h the ligands
were added together with the serum-containing medium. The medium
was replaced 24 h later with the fresh medium containing ligands, and
after 48 h the cells were washed with PBS bu¡er and harvested.
The cell lysates were obtained by 3^4 cycles of freezing and thawing
in a solution of 0.1 M potassium phosphate, pH 8.0, 1 mM DTT and
0.05% Triton. Luciferase activity was measured with the Lumat LB
9501 from Berthold, and normalized with L-galactosidase activities
that served as the internal control.
3. Results
3.1. Cloning and sequencing of PPARQ1 cDNA from the duck
uropygial gland
A 180-bp cDNA fragment obtained by PCR using degen-
erate primers and uropygial gland cDNA as template was
con¢rmed to be a PPAR fragment by sequencing. This
PPAR cDNA fragment was used as a probe to screen a
cDNA library of duck uropygial gland. The nucleotide se-
quencing of four cDNA clones thus obtained showed that a
2.4-kb clone contained the complete open reading frame,
while another clone of 1.2 kb was found to be a fragment
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of the 2.4-kb clone. The other two clones, which were about
2.7 kb in size, were found to be identical to each other. The 5P
ends of these were identical to that of the ¢rst clone, but their
3P ends were 352 bp longer than that of the 2.4-kb clone. The
nucleotide sequence and the predicted amino acid sequence of
the protein encoded by the open reading frame are shown in
Fig. 1. The amino acid sequence has an overall 90% identity
with human, hamster and mouse PPARQ1. Most of the con-
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Fig. 1. Alignment of the amino acid sequence of duck PPARQ 1 with other PPARQ proteins. The conserved regions among all of the proteins
are shaded. The hamster PPARQ1 was from Chinese hamster CHO cells. Mouse PPARQ1 was from mouse liver. The human PPARQ1 was also
from liver.
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served amino acids were found to be located in the regions of
both DNA binding and ligand binding domains.
3.2. PPARK in the uropygial gland of the duck
It is well known that PPARK, the most inducible subtype of
receptor, plays a major role in peroxisome proliferation in the
rodent liver. We examined its expression in the duck uropygial
gland, where estradiol-induced peroxisome proliferation oc-
curs [29]. For this purpose we cloned PPARK from duck by
RT-PCR. When RT-PCR was performed with primers speci¢c
for the K isoform, RNA from liver, kidney and uropygial
gland yielded a 519-bp fragment. The nucleotide sequence of
the partial duck PPARK cDNA clone showed 90% homology
to PPARK from other sources (data not shown). Northern
blot analysis with this DNA fragment as probe showed that
PPARK was expressed in heart and uropygial gland at a high-
er level than in the other tissues, although it was also ex-
pressed in kidney and liver (Fig. 2A). When the transcript
levels of PPARK and PPARQ were compared on the same
blot, the level of expression of the Q isoform was found to
be higher than that of the K form in the uropygial gland,
suggesting the importance of duck PPARQ in the overall lipid
metabolism in the duck uropygial gland. The co-expression of
PPARK and Q in the duck uropygial gland probably re£ects
the extensive and active lipid metabolism in this tissue.
3.3. Expression of PPARQ1 speci¢cally in the duck uropygial
gland
Northern blot analysis showed that duck PPARQ was
uniquely and highly expressed in the uropygial gland when
compared with other tissues. Its expression was also detected
in kidney and spleen, but at much lower level (Fig. 2A). PPARQ
transcripts were also detected in liver when primer extension
analysis was done with high levels of mRNA (Fig. 3). Fur-
thermore, there were two transcripts which were close to each
other in size, and both were about 4.4 kb long (Fig. 4). We
identify them as duck PPARQ1 and Q2 based on the ¢ndings in
mouse and human [6,7]. The two transcripts were found to be
expressed at similar levels. This ¢nding constitutes the ¢rst
known example of a tissue where PPARQ1 is a major
PPAR. We also examined the expression of PPARQ by North-
ern blot in the goose uropygial gland, where estrogen does not
induce peroxisome proliferation (P.E. Kolattukudy, unpub-
lished data). No PPARQ expression was detected in the liver,
but unlike in the duck, only one of the two transcripts, cor-
responding to PPARQ2, was detected at high levels in the
goose uropygial gland. Thus, the occurrence of PPARQ1 as
a major PPAR seems to be a unique feature of a tissue that
responds to estrogen treatment by peroxisome proliferation.
In order to determine if any isoform of PPARQ was highly
expressed exclusively in the duck uropygial gland, primer ex-
tension analysis was performed with a 30-mer oligonucleotide
which was complementary to the region of 29^59 nucleotide
position downstream of the start site of the open reading
frame of the duck PPARQ1. Since the 5P end of the cDNA
sequence of the PPARQ2 was not known, other known se-
quencing reactions were included in parallel to serve as size
markers. Three transcripts were detected, two of which were
only di¡erent by ¢ve or six nucleotides in length, while the
other was at least 120 bp longer (Fig. 5). The two shorter
transcripts were too short to contain the full length of the
open reading frame of the Q2 form and therefore are identi¢ed
as PPARQ1. The results showed that PPARQ1 was highly ex-
pressed speci¢cally in the duck uropygial gland while PPARQ2
was highly expressed in both duck and goose uropygial gland.
Since our initial interest was to ¢nd the molecular basis for
the estrogen-induced peroxisome proliferation in the duck ur-
opygial gland, we examined by Northern blots whether estra-
diol treatment caused any changes in the relative levels of
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Fig. 2. A: RNA blots showing the tissue distribution of duck PPARK
and PPARQ. Two Wg of mRNA from each tissue and 32P-labeled
probes were used, as described in Section 2. B: RNA blots showing
the expression of duck PPARK and PPARQ in the uropygial gland
during the treatment of the ducks with 17L-estradiol. Two Wg of
mRNA from each tissue was applied. The numbers represent the
days of 17L-estradiol treatment.
Fig. 3. Primer extension analysis of the PPAR transcripts from
duck kidney and liver. Ten Wg of duck kidney mRNA and 20 Wg of
liver mRNA were used.
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PPARQ (Fig. 2B). The uropygial gland secretion samples col-
lected after treatment of the ducks for the various periods of
time were analyzed by thin-layer chromatography. In the be-
ginning, the secretion consisted exclusively of short chain es-
ters of fatty alcohols; after 3 days of estradiol treatment,
longer chain esters appeared and became the sole product
by 9 days of treatment. By 12 days diesters, the characteristic
product of peroxisomes, became the dominant component of
the secretion demonstrating peroxisome proliferation. The lev-
el of expression of PPARQ slightly decreased within the ¢rst
several days, and then recovered to the original level and
remained steady by the time of peroxisome proliferation.
Therefore we conclude that estrogen did not induce the ex-
pression of PPARQ at the mRNA level. We did not detect any
changes in PPARQ1/PPARQ2 ratios resulting from estrogen
treatment.
3.4. Activation of duck PPARQ1 by peroxisome proliferators
and prostaglandins
To test for the function of the duck PPARQ1, we expressed
it in NIH 3T3 cells that are known to have the low back-
ground of PPARQ and high level of expression of RXR that
would be necessary for the transactivating activity of PPARQ
[19]. The cells were also cotransfected with a luciferase report-
er plasmid in which three copies of PPRE derived from the rat
fatty acyl-CoA oxidase promoter were inserted as enhancer.
The transient transfection showed that the duck PPARQ1 was
activated by peroxisome proliferators such as 100 WM Wy-
14 643 and clo¢bric acid as well as 33 WM Ly-171 883, and
gave rise to up to 3^4-fold induction of the target gene. By
cotransfection with mRXRK the maximum induction up to
7^9-fold was observed (Fig. 6). However, when the prosta-
glandins were tested it was found that prostaglandin D2 and
its metabolites, the prostaglandin J2 series, were able to induce
the target gene expression by 5^6-fold at much lower concen-
trations (Fig. 7).
4. Discussion
To investigate the mechanisms involved in the induction of
peroxisome proliferation by estrogen in its target tissue, the
uropygial gland of the duck, we cloned PPAR from this tis-
sue. This is the ¢rst PPAR to be cloned from an avian system.
The level of expression of the two isoforms of PPARQ was
found to be signi¢cantly high in duck uropygial gland.
Although it has been known that PPARQ is predominantly
expressed in adipose tissue and is considered as the adipocyte
determination factor [13,24,31], the actual functions of the
two Q isoforms are not clear. The evidence that the PPARQ
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Fig. 4. The expression of PPARQ isoforms in duck and goose uro-
pygial gland and liver as detected by Northern blot. In the goose
uropygial gland the top band was found to be at a much lower level
than in the duck uropygial gland. Two Wg of mRNA from each tis-
sue and 32P-labeled probes were used, as described in Section 2.
Fig. 5. Primer extension analysis of the PPAR transcripts from
goose and duck uropygial glands. Three transcripts were detected in
the duck uropygial gland, while two of them were absent in the
goose uropygial gland. 100 Wg of duck uropygial gland total RNA
and 60 Wg of goose uropygial gland total RNA were used.
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expressed in rodent adipose tissue is mainly PPARQ2 and the
observation that expression of PPARQ2 mRNA was increased
in human obesity suggests that PPARQ2 may be responsible
for the adipose di¡erentiation [24,28]. However, it has been
shown that the N-terminal domain of PPARQ2 is not required
for its adipogenic activity [24], and both Q1 and Q2 isoforms
can bind to DR-1 (direct repeat with one nucleotide spacing)
response elements, which have been identi¢ed in the pro-
moters of genes which encode peroxisomal enzymes and of
murine-speci¢c adipocyte gene P2 [32,33]. In addition, thiazo-
lidinediones including BRL-49 653 can activate the two iso-
forms of human and mouse PPARQ at similar levels [7,34].
Our results show that PPARQ2 is present in both duck and
goose uropygial gland, but PPARQ1 is expressed only in the
duck. This result further emphasizes the di¡erence between
the two PPARQ isoforms. Both duck and goose uropygial
glands specialize in the production of large amounts of secre-
tory lipids, just as adipose tissue produces large amounts of
storage lipids. On the other hand, estrogen-induced peroxi-
some proliferation occurs only in the uropygial gland of the
duck, but not of the goose. Therefore it is reasonable to sug-
gest that PPARQ1 is involved in estrogen-induced peroxisome
proliferation, while PPARQ2 is essential for adipogenesis.
Since the two PPARQ isoforms have the ability to transacti-
vate the same target genes and respond to the same group of
ligands [24], the di¡erence in their functions is not clear. One
possibility is that the additional segment found uniquely in
PPARQ2 is involved in the regulating interaction between
PPARQ2 and other nuclear receptors, coactivators, or regula-
tors involved in the process of adipogenesis. In fact it is
known that a basic leucine zipper transcription factor C/
EBP can also bind to and activate the promoters of several
adipocyte genes, and the optimal stimulation of adipocyte
di¡erentiation is obtained by the combined expression of
PPARQ2 and C/EBPK [24,33]. PPARQ was also found to in-
teract with steroid receptor coactivator (ARC-1) and CBP, the
protein that binds cAMP response element binding protein
(CREB), which is a co-factor of transcription regulation of
various genes [35,36]. Recently a 165-kDa protein was re-
ported to be a coactivator of PPARQ and at least the C-ter-
minus of PPARQ was responsible for the interaction [36].
However, the role of the N-terminus of PPARQ was not clear.
Another possible regulation might be through phosphoryla-
tion, since it has been shown that when activated by PGF2,
MAP kinase (mitogen-activated protein kinase) can block adi-
pogenesis through inhibitory phosphorylation of PPARQ [37].
It is likely that two di¡erent forms are used so that di¡erent
factors can regulate their expressions to meet speci¢c biolog-
ical functions. Since the uropygial gland is a holocrine gland,
it contains cells at di¡erent stages of di¡erentiation. It is pos-
sible that the two isoforms occur at di¡erent levels in the cells
FEBS 20779 3-9-98
Fig. 6. Activation of duck PPARQ1 by peroxisome proliferators.
NIH 3T3 cells were transfected by the duck PPARQ1 expression vec-
tor, the mouse RXR expression vector and the PPRE luciferase re-
porter plasmid. The activators or solvent alone (control) were added
to the cell culture medium at the concentrations indicated. The luci-
ferase activities were measured, and the fold inductions were nor-
malized by L-galactosidase activities in the same extracts. Each reac-
tion was done in triplicate. The reference fold induction refers to
PPRE luciferase reporter alone in the presence of solvent. Wy: Wy-
14 643; Ly: Ly-171 883; RA: cis-9-retinoic acid; CFA: clo¢bric
acid.
Fig. 7. Activation of duck PPARQ1 by prostaglandins. The trans-
fected NIH 3T3 cells were treated with 10 WM or 2 WM of each of
the indicated prostaglandins. Other experimental details are the
same as in Fig. 6. Prostaglandin A2 and prostaglandin J2 series
were toxic to cells at 10 WM.
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at di¡erent stages of di¡erentiation. This gland has many
features of adipocytes, as well as the unique feature of pro-
ducing the specialized secretory lipids. Thus, the occurrence of
PPARQ2, which is found in adipocytes, and the occurrence of
PPARQ1 as a major receptor in this gland might imply some
functional uniqueness for the two Q isoforms.
Estrogen-induced peroxisome proliferation is a special fea-
ture of duck uropygial glands. The unique presence of PPARQ1
as a major PPAR in this tissue implies that this form may be
involved in peroxisome proliferation. The microbodies pro-
duced by this hormonal induction generate diesters of 3-hy-
droxy C8, C10 and C12 fatty acids [28]. This process may
require activation of a slightly di¡erent mix of genes from
those involved in peroxisome proliferation in the liver, where
L-oxidation of fatty acids may be the major function. The
induction of the biosynthetic microbodies in the gland may
involve di¡erent ligands than those that trigger peroxisome
proliferation in the liver. Thus, the two processes probably
require a unique mix of interacting transcription factors, in-
cluding the PPARQ1. The molecular partners that interact
with PPARQ1 and the mechanisms of their transcriptional
activation of the target genes remain to be elucidated. How
estrogen causes peroxisome proliferation via PPARQ is not
understood. Although estrogen could induce genes regulated
by PPAR responsive elements in a cell culture, the degree of
induction was thought to be too low to account for the ob-
served peroxisome proliferation and an indirect mechanism
was suggested when it was found that estradiol treatment
induced the synthesis of a prostaglandin D2 metabolite that
was found to be a potent ligand for PPARQ [38].
Peroxisome proliferation in the liver is associated with tu-
morigenesis, presumably mediated via the oxidative damage
to the DNA caused by the oxidant produced by fatty acid
oxidases [2]. The microbodies produced in the uropygial gland
as a result of estrogen treatment also produce fatty acid ox-
idase, and probably cause oxidative damage to DNA. How-
ever, since this is a holocrine gland, the cells in which such
DNA damage might occur would lyse, emptying the cell con-
tents into the lumen for secretion. Therefore, this hormone-
induced peroxisome proliferation would not cause lasting
changes such as transformation and tumorigenesis. On the
other hand, if estrogen-induced peroxisome proliferation oc-
curs in the target tissues in mammals, tumorigenesis may re-
sult. Whether such hormone-induced peroxisome proliferation
occurs just prior to tumorigenesis is not known.
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